- Report
- March 2025
- 1048 Pages
Global
From €4184EUR$4,799USD£3,639GBP
- Report
- January 2026
- 192 Pages
Global
From €3434EUR$3,939USD£2,986GBP
- Drug Pipelines
- July 2025
- 280 Pages
Global
From €2616EUR$3,000USD£2,275GBP
- Report
- November 2025
- 183 Pages
Global
From €3923EUR$4,500USD£3,412GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1744EUR$2,000USD£1,516GBP
- Report
- October 2025
- 163 Pages
Global
From €3500EUR$4,300USD£3,150GBP
- Report
- January 2026
- 180 Pages
Global
From €3434EUR$3,939USD£2,986GBP
- Report
- September 2025
- 250 Pages
Global
From €3915EUR$4,490USD£3,404GBP
- Report
- September 2025
- 250 Pages
Global
From €3915EUR$4,490USD£3,404GBP
- Report
- September 2025
- 250 Pages
Global
From €3915EUR$4,490USD£3,404GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1744EUR$2,000USD£1,516GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1744EUR$2,000USD£1,516GBP
- Report
- September 2025
- 950 Pages
Global
From €4355EUR$4,995USD£3,787GBP
- Report
- February 2026
- 281 Pages
Global
From €6099EUR$6,995USD£5,304GBP
- Report
- May 2025
- 472 Pages
Global
From €6099EUR$6,995USD£5,304GBP
- Report
- February 2026
- 262 Pages
Global
From €6099EUR$6,995USD£5,304GBP
- Report
- February 2026
- 388 Pages
Global
From €6099EUR$6,995USD£5,304GBP
- Report
- October 2025
- 598 Pages
Global
From €4184EUR$4,799USD£3,639GBP
- Report
- December 2025
- 391 Pages
Global
From €4184EUR$4,799USD£3,639GBP
- Report
- February 2026
- 656 Pages
Global
From €4184EUR$4,799USD£3,639GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more